Rhythm Biosciences flags positive data for lung cancer diagnostic test

The Market Herald2023-11-24

Together with the Baker Institute, Rhythm identifies best five-biomarker combination that can target the various stages of lung cancer The company used a cohort of 70 healthy and cancerous patients ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2385605657?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-11-24 10:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2385605657","market":"hk","top_or_hot":-1,"title":"Rhythm Biosciences flags positive data for lung cancer diagnostic test","media":"The Market Herald","content":"<div>\n<p>Together with the Baker Institute, Rhythm identifies best five-biomarker combination that can target the various stages of lung cancer \nThe company used a cohort of 70 healthy and cancerous patients\n...</p>\n\n<a href=\"https://themarketherald.com.au/rhythm-biosciences-flags-positive-data-for-lung-cancer-diagnostic-test-2023-11-24/\">Source Link</a>\n\n</div>\n","source":"markerherald_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rhythm Biosciences flags positive data for lung cancer diagnostic test</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRhythm Biosciences flags positive data for lung cancer diagnostic test\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-11-24 10:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://themarketherald.com.au/rhythm-biosciences-flags-positive-data-for-lung-cancer-diagnostic-test-2023-11-24/><strong>The Market Herald</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Together with the Baker Institute, Rhythm identifies best five-biomarker combination that can target the various stages of lung cancer \nThe company used a cohort of 70 healthy and cancerous patients\n...</p>\n\n<a href=\"https://themarketherald.com.au/rhythm-biosciences-flags-positive-data-for-lung-cancer-diagnostic-test-2023-11-24/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7124","symbol_name":"保健护理服务","start_time":0,"source_url":"https://themarketherald.com.au/rhythm-biosciences-flags-positive-data-for-lung-cancer-diagnostic-test-2023-11-24/","article_id":"2385605657","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2385605657","pubTimestamp":1700793240,"sourceInfo":{"source_id":"markerherald_stock","name":"The Market Herald"},"weMediaInfo":null,"summary":"Together with the Baker Institute, Rhythm identifies best five-biomarker combination that can target the various stages of lung cancer. The company used a cohort of 70 healthy and cancerous patients. The results could lead to these biomarkers being translated into a commercial treatment. Rhythm Biosciences  has received positive preliminary data from the Baker Institute in regard to its lung cancer diagnostic test.Rhythm reports successfully identifying a five-biomarker combination that can target the various stages of lung cancer.A preliminary assessment of up to 17 biomarkers was performed on 71 healthy volunteers and 70 lung cancer patients.Shares, however, remained flat in the second hour of trade.Originally for research only, these biomarkers have proven they can distinguish between healthy and cancerous controls.Rhythm has stated the results require further analysis through a larger cohort to justify continuing the project.This it expects to support the case for further investmen","collect":0,"end_time":0,"defaultTopTitle":"themarketherald.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7124":"保健护理服务","RHY.AU":"RHYTHM BIOSCIENCES LTD"},"translate_title":"Rhythm Biosciences标记肺癌诊断试验阳性数据","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RHY.AU":1},"content_text":"Together with the Baker Institute, Rhythm identifies best five-biomarker combination that can target the various stages of lung cancer \nThe company used a cohort of 70 healthy and cancerous patients\nIt will now move towards a larger study\nThe results could lead to these biomarkers being translated into a commercial treatment \nRHY shares are trading at 18 cents at 10:19 am AEDT\n\nRhythm Biosciences (RHY) has received positive preliminary data from the Baker Institute in regard to its lung cancer diagnostic test.\nRhythm reports successfully identifying a five-biomarker combination that can target the various stages of lung cancer.\nA preliminary assessment of up to 17 biomarkers was performed on 71 healthy volunteers and 70 lung cancer patients.\nShares, however, remained flat in the second hour of trade.\nResults better than expected \nOriginally for research only, these biomarkers have proven they can distinguish between healthy and cancerous controls. \nRhythm has stated the results require further analysis through a larger cohort to justify continuing the project.\nThis it expects to support the case for further investment to advance all clinical possibilities.\nThe value of detecting lung cancer is obvious enough, but especially pertinent given that most patients report with symptoms too late.\nLeading cause of cancer death\n“These encouraging results warrant confirmation in a larger population and justify the continuation and advancement of the project,” Rhythm Biosciences wrote on Friday.\n“Lung cancer remains the leading cause of cancer-related deaths worldwide, primarily because most people present when the stage is too advanced to offer any reasonable chance of cure.\n“The Australian Institute of Health and Welfare estimated that in 2022, 14,529 Australians were diagnosed with lung cancer, and more than 8,6064 died from the disease.”\nRHY shares were trading at 18 cents at 10:19 am AEDT.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2385605657"}